Denise Bronner, Ph.D., makes the case for and against acquisitions for rejuvenating Big Pharma pipelines. She explains why ...

Current short-acting opioid rescue agents were not designed to counteract oral fentanyl overdoses, and the mismatch can be ...

A prominent national life sciences service company is offering innovative solutions to North Carolina startups by providing access to state-of-the-art facilities in Morrisville. These turnkey spaces ...

North Carolina's life sciences ecosystem is flourishing, largely due to the visionary leadership and innovative spirit of women who are shaping its future. These trailblazers are making significant ...

Riding for the British Cycling team was a foundational experience for Ian Thompson, SVP and general manager of U.S. business operations at Amgen. During a recent conversation about his 16-year tenure ...

Today we're talking life sciences investment trends and risks with David Sans, an investment banker with an academic background in chemical engineering and molecular modeling, and a professional ...

On today's episode of the Business of Biotech, we're speaking with Sara Bonstein, Chief Financial Officer at Insmed, about what it takes to be a successful CFO. Sara provides useful insights on how to ...

Medical affairs can no longer afford to operate within legacy structures. Enter AI-enabled functional service provider (FSP) models that offer operational relief.

With the recent sign-off from the FDA on protocols for a pivotal Phase 3 trial of IMNN-001 in advanced ovarian cancer, Imunon is poised to bring its IL-12 DNA plasmid vector (encased in a nanoparticle ...

Artificial intelligence is revolutionizing the life sciences industry by driving innovation in various domains, such as drug discovery, clinical trials, and regulatory compliance. While AI offers the ...